“…Involved-field radiotherapy 35 Gy was indicated in some patients with bulky disease or incomplete resection (Novakovic et al, 2006), but it is used almost exclusively with palliative purposes. Combined treatment modality with debulking surgery followed by systemic anthracycline-containing polichemotherapy, with or without consolidation radiotherapy, showed an ORR of 58%, a 5-year FFS of 3% and a 5-year OS of 20-25% (Domizio et al, 1993, Gale et al, 2000, d'Amore et al, 1994, Morton et al, 1993. Many patients are unable to complete the chemotherapy program and do not receive radiotherapy due to rapid disease progression, poor nutritional and performance status, associated with local and systemic complications (Daum et al, 2003, Gale et al, 2000.…”